Journals / Türk Oftalmoloji Dergisi / 2011 / Cilt: 41 - Sayı: 6

The significance of ocular findings in the diagnosis of fabry’s disease

Oküler bulguların fabry hastalığı tanısındaki önemi

Pages
414–416
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We report the clinical and confocal microscopic findings of cornea verticillata observed in a patient who was diagnosed as Fabry’s disease. (Turk J Oph thal mol 2011; 41: 414-6)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Fabry’s disease is an X-linked, inherited disorder caused by a deficiency of the enzyme alfa-galactosidase A and characterized by progressive accumulation of glycosphingolipids within several tissues and organs, including the eye.
📊
Key Findings & Data:Ocular findings of Fabry’s disease are cornea verticillata, conjunctival vascular changes, retinal vessel tortuosity and cataract.
💡
Conclusion & Impact:We report the clinical and confocal microscopic findings of cornea verticillata observed in a patient who was diagnosed as Fabry’s disease. (Turk J Oph thal mol 2011; 41: 414-6)
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Fabry’s disease is an X-linked, inherited disorder caused by a deficiency of the enzyme alfa-galactosidase A and characterized by progressive accumulation of glycosphingolipids within several tissues and organs, including the eye. Ocular findings of Fabry’s disease are cornea verticillata, conjunctival vascular changes, retinal vessel tortuosity and cataract. We report the clinical and confocal microscopic findings of cornea verticillata observed in a patient who was diagnosed as Fabry’s disease. (Turk J Oph thal mol 2011; 41: 414-6)

Özet

Fabry hastalığı, X’ e bağlı geçiş gösteren, alfa-galaktozidaz A enzim eksikliğinin neden olduğu, göz de dahil çeşitli doku ve organlarda glikosfingolipidlerin ilerleyici birikimiyle karakterize bir hastalıktır. Fabry hastalığının oküler bulguları arasında kornea vertisillata, konjonktival vasküler değişiklikler, retinal damarlarda tortuosite ve katarakt yer almaktadır. Çalışmamızda kornea bulgularının tespitinden sonra Fabry hastalığı tanısı alan bir erkek hastanın klinik ve konfokal mikroskopi bulguları incelenmiştir. (Turk J Ophthalmol 2011; 41: 414-6)

🔖

Cite This Article

HÜRMERİÇ, V., ERDURMAN, F. C., ÖZGÖNUL, C., ERDEM, Ü., CEYLAN, O. M. (2022). The significance of ocular findings in the diagnosis of fabry’s disease. Türk Oftalmoloji Dergisi, Cilt: 41 - Sayı: 6, 414–416. https://ajindex.com/articles/638361

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Clarke JT. Narrative review: Fabry disease. Ann Intern Med. 2007;146:425-33
  2. Mehta A, Ricci R, Widmer U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest. 2004;34:236-42
  3. Kalkan Uçar S. Fabry Hastalığı (Ege Üniversitesi Tıp Fakültesi Tarama Sonuçları). J LSD 2010;2;35-5
  4. Sodi A, Ioannidis AS, Mehta A, Davey C, Beck M, Pitz S. Ocular manifestations of Fabry’s disease: data from the Fabry Outcome Survey. Br J Ophthalmol. 2007;91:210-4
  5. Sher NA, Letson RD, Desnick RJ. The ocular manifestations in Fabry’s disease. Arch Ophthalmol. 1979;97:671-6
  6. Mehta A, Beck M, Elliott P, et al. Enzyme replacement therapy with agalsidase alfa in patients with Fabry’s disease: an analysis of registry data. Lancet. 2009;374:1986-96
  7. Hollander DA, Aldave AJ. Drug-induced corneal complications. Curr Opin Ophthalmol. 2004;15:541-8
  8. Muftuoglu O, Uçakhan OO, Kanpolat A. Clinical and In Vivo Confocal Microscopy Findings in Patients Receiving Tamoxifen Citrate. Eye Contact Lens. 2006;32:228-32
  9. Mastropasqua L, Nubile M, Lanzini M, Carpineto P, Toto L, Ciancaglini M. Corneal and Conjunctival Manifestations in Fabry Disease: In Vivo Confocal Microscopy Study. Am J Ophthalmol. 2006;141:709-18
  10. Falke K, Büttner A, Schittkowski M, et al. The microstructure of cornea verticillata in Fabry disease and amiodarone-induced keratopathy: a confocal laser-scanning microscopy study. Graefes Arch Clin Exp Ophthalmol. 2009;247:523-34
  11. Tavakoli M, Marshall A, Thompson L, et al. Corneal confocal microscopy: A novel noninvasive means to diagnose neuropathy in patients with fabry disease. Muscle Nerve. 2009;40:976-84
  12. Nguyen TT, Gin T, Nicholls K, Low M, Galanos J, Crawford A. Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre. Clin Experiment Ophthalmol. 2005;33:164-8
  13. Tuppurainen K, Collan Y, Rantanen T, Hollmen A. Fabry’s disease and cornea verticillata. A report of 3 cases. Acta Ophthalmol (Copenh).1981;59:674-82
  14. Franceschetti AT. Fabry disease: ocular manifestations. Birth Defects Orig Artic Ser. 1976;12:195-208.